Homo sapiens BXPC3 cells transcriptome sequencing raw data
收藏NIAID Data Ecosystem2026-05-02 收录
官方服务：
资源简介：
identify differential genes for drug combination in pancreatic cancer
应用场景：
创建时间：
2024-05-22
相关数据集
Next Generation Sequencing Facilitates Quantitative Analysis of shNC/sh337/ and EV/337 Transcriptomes
Purpose: Next-generation sequencing (NGS) has revolutionized systems-based analysis of cellular pathways. The goals of this study are to compare PDAC cell silencing or overexpressing linc00337 with c
NIAID Data Ecosystem110
Table S3 from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
Differentially expressed and modular genes for each archetype cluster, including upregulated genes (log₂ fold change > 1, p < 0.05) and Hotspot-identified informative genes with significant autocorrel
NIAID Data Ecosystem20
The tissue factor-thrombin axis drives pancreatic ductal adenocarcinoma through tumor cell-derived PAR-1. The tissue factor-thrombin axis drives pancreatic ductal adenocarcinoma through tumor cell-derived PAR-1
RNA-Seq analysis reporting the transcriptional changes induced by treatment of mouse pancreatic ductal adenocarcinoma cell lines with thrombin for 24h Overall design: Total mRNA profiles from C57Bl/6
NIAID Data Ecosystem20
EZH2-GATA6 axis in Pancreatic ductal adenocarcinoma [RNA-Seq]
We conducted RNA-seq experiments to investigate the role of EZH2 in Pancreatic ductal adenocarcinoma Overall design: RNA-seq profiles for EZH2 in NKC cells (mouse PDAC cell line carrying pancreas spec
NIAID Data Ecosystem90
RNA-seq analysis of human pancreas cell line SU8686 treated with DOT1L inhibitor (SGC0946) or DMSO
To understand the pathway alteration associated with DOT1L inhibition, we performed RNA-seq analysis of DOT1L inhibitor treated human pancreas cell line SU8686. We reported the changed pathways. Overa
NIAID Data Ecosystem20
